C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/88 (2006.01) A61K 31/135 (2006.01) A61K 31/165 (2006.01) A61K 31/17 (2006.01) A61K 31/197 (2006.01) A61K 31/27 (2006.01) A61K 31/45 (2006.01) C07C 211/27 (2006.01) C07C 229/08 (2006.01) C07C 229/22 (2006.01) C07C 237/22 (2006.01) C07C 275/28 (2006.01)
Patent
CA 2626178
The present invention relates to compounds which are useful for reducing levels of TNF.alpha. in a mammal. Examples of compounds include those of formula: Image wherein, for example, R7 is a cyclic alkyl, a substituted phenyl, etc ...; n is 1 and R12 is an alkoxy, a disubstituted amino, etc ...; those of formula: Image wherein, for example, Z is Image or R4 NH- n is 1, 2 or 3; R1 is a divalent residue of 3,4-pyridine, pyrrolidine, etc ...; R2 is -CO- or -SO2-; R3 is a substituted phenyl, pyridyl, etc ...; and R4 is alanyl, argynyl, etc.
Celgene Corporation
Smart & Biggar
LandOfFree
Process for the preparation of thalidomide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of thalidomide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of thalidomide will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1894143